Market News & Trends
Upperton Pharma Solutions Wins Champion Award at 2025 CDMO Leadership Awards in Small Molecule Dosage Form Category
Upperton Pharma Solutions is proud to announce its selection as Champion Winner in the Small Molecule Dosage Form – International category at the 2025 CDMO…
Traws Pharma’s Bird Flu Drug Candidate Presented at ICAR
Traws Pharma, Inc. recently announced that positive data supporting the potential for tivoxavir marboxil (TXM) as a bird flu treatment was presented yesterday in a…
Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204
Silexion Therapeutics Corp. recently announced it has completed an expanded development plan for its next-generation siRNA candidate, SIL204, which the company’s management will be presenting…
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
Wugen, Inc. recently announced the dosing of the first patients in its pivotal Phase 2 study evaluating WU-CART-007, a potential first-in-class, investigational, anti-CD7 CAR-T cell…
Evestia Clinical Launches as a Market Leading Pharmaceutical Research Specialist Focused on Clinical Trials in Oncology & Rare Diseases
Evestia Clinical has today been announced as the new identity of EMAS Pharma, as it sets its sights on rapid growth as a provider of…
Esperion Aligns With FDA to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous & Homozygous Familial Hypercholesterolemia
Esperion recently announced that following meetings with the US FDA, it has gained alignment on a regulatory path forward for initiating Phase 3 studies of…
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
Indaptus Therapeutics, Inc. recently provided an update on key pharmacodynamic findings from the weekly dosing cohort of its ongoing Phase 1 trial of Decoy20. As…
Candel Therapeutics & IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
Candel Therapeutics, Inc. together with IDEA Pharma, a Division of SAI MedPartners (IDEA) recently announced a strategic commercial partnership. Under this agreement, IDEA will provide…
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer
BriaCell Therapeutics Corp. recently announced the external Data Safety Monitoring Board (DSMB), an independent group of experts who review and monitor the safety data of…
Dyadic Announces Funding Award to Use C1 to Accelerate Development of Protein-Based Vaccines
Dyadic International, Inc. recently announced it has received a funding award from CEPI to use C1 to accelerate the development of protein-based vaccines. CEPI is…
Longeveron Announces Positive Type B Meeting With FDA Regarding Pathway to BLA for Laromestrocel in Alzheimer’s Disease
Longeveron Inc. recently announced the positive outcome of a Type B meeting with the US FDA, supporting the advancement of laromestrocel (Lomecel-B), a proprietary, scalable,…
Acumen Pharmaceuticals Announces Topline Results From Phase 1 Study of Subcutaneous Formulation of Sabirnetug
Acumen Pharmaceuticals, Inc. recently announced topline results from its Phase 1 study comparing pharmacokinetics (PK) between subcutaneous (SC) and intravenous (IV) formulations of sabirnetug in healthy…
Conduit Pharmaceuticals Provides R&D Update on Progress for Pipeline Assets
Conduit Pharmaceuticals Inc. recently provided an R&D update on the development progress of pipeline assets AZD1656, AZD5658, and AZD5904. The Company has made significant progress…
Genenta Announces $21.9M Financing to Expand Pipeline as Brain Tumor Trial is Showing Promising Survival Rates
Genenta Science recently announced a $21.9 million financing through the issuance of a Mandatory Convertible Bond to ENEA Tech and Biomedical (ETB) to support the expansion…
Tract Bio Announces Publication in Gastroenterology Potential Targets for Esophageal Adenocarcinoma Identified Using stemECHOTM Cloning Platform
Tract Bio recently announced the publication of preclinical research in Gastroenterology. The article, “Evolution of Esophageal Adenocarcinoma from Precursor Lesion Stem Cells” describes results from…
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Curevo Vaccine recently announced the closing of a $110-million Series B round to advance development of amezosvatein, its vaccine for shingles. Leading the round is…
llarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients
Allarity Therapeutics, Inc. announced the presentation of new clinical data from its ongoing Phase 2 trial with stenoparib monotherapy in advanced Ovarian Cancer at the…
Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites
Curia Global, Inc. recently announced expansion plans to its Glasgow, UK, facility and provided updates on the ongoing expansion in Albuquerque, NM. Curia’s sterile fill-finish…
GRIN Therapeutics Receives FDA Orphan Drug Designation for Treatment of GRIN-Related Neurodevelopmental Disorder Treatment
GRIN Therapeutics, Inc. recently announced the US FDA granted Orphan Drug designation for its investigational drug, radiprodil, for the treatment of GRIN-related neurodevelopmental disorder (NDD).…
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Cellphire Therapeutics, Inc. recntly announced the US FDA has granted Fast Track designation for CLPH-511 (Frozen Activated Platelets) Injectable Suspension for the treatment of acute…
